ENGAGE AF-TIMI 48: Tailoring Edoxaban Dose Preserves Drug Efficacy and Safety

Article Figures & Data

Figures

  • Figure 1.

    Primary Outcome With Maintained or Lowered High- and Low-Dose Edoxaban

    Edox, edoxaban; FXa, factor Xa; HD, high-dose; LD, low-dose; NA, not applicable; SEE, systemic embolic event.Reproduced with permission from C Ruff, MD, MPH.
  • Figure 2.

    Annual Risk for Major Bleeding

    Edox, edoxaban; FXa, factor Xa; HD, high-dose; LD, low-dose; NA, not applicable; SEE, systemic embolic event.Reproduced with permission from C Ruff, MD, MPH.
  • Figure 3.

    Annual Risk for Intracranial Hemorrhage

    Edox, edoxaban; FXa, factor Xa; HD, high-dose; LD, low-dose; NA, not applicable; SEE, systemic embolic event.Reproduced with permission from C Ruff, MD, MPH.